Technical Analysis for PTN - Palatin Technologies, Inc.

Grade Last Price % Change Price Change
D 0.782 -4.63% -0.04
PTN closed down 4.63 percent on Friday, February 26, 2021, on 37 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical PTN trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Spinning Top Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -4.63%
Calm After Storm Range Contraction -4.63%
Wide Bands Range Expansion -4.63%
Oversold Stochastic Weakness -4.63%
Crossed Above 50 DMA Bullish -8.31%
Calm After Storm Range Contraction -8.31%
Older End-of-Day Signals for PTN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biopharmaceutical Diseases Molecular Biology Drug Development Dysfunction Endocrine System Obesity Peptides C Peptide Male Sexual Dysfunction Melanocortin Sexual Dysfunction Treatment Of Obesity

Is PTN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.3
52 Week Low 0.35
Average Volume 8,694,365
200-Day Moving Average 0.58
50-Day Moving Average 0.83
20-Day Moving Average 0.97
10-Day Moving Average 0.91
Average True Range 0.11
ADX 28.54
+DI 20.32
-DI 29.19
Chandelier Exit (Long, 3 ATRs ) 0.97
Chandelier Exit (Short, 3 ATRs ) 1.06
Upper Bollinger Band 1.23
Lower Bollinger Band 0.70
Percent B (%b) 0.15
BandWidth 55.04
MACD Line -0.01
MACD Signal Line 0.03
MACD Histogram -0.0429
Fundamentals Value
Market Cap 179.78 Million
Num Shares 230 Million
EPS 0.15
Price-to-Earnings (P/E) Ratio 5.18
Price-to-Sales 792.23
Price-to-Book 1.34
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.86
Resistance 3 (R3) 0.87 0.84 0.85
Resistance 2 (R2) 0.84 0.82 0.84 0.85
Resistance 1 (R1) 0.81 0.81 0.80 0.81 0.84
Pivot Point 0.79 0.79 0.78 0.79 0.79
Support 1 (S1) 0.76 0.77 0.75 0.75 0.72
Support 2 (S2) 0.73 0.75 0.73 0.72
Support 3 (S3) 0.70 0.73 0.71
Support 4 (S4) 0.70